Clinical Trial: Chemotherapy combined with immunotherapy and targeted drugs, along with concurrent or sequential radiotherapy, for the treatment of locally advanced unresectable esophageal cancer: A retrospective comparative study on safety and efficacy (China)

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Chemotherapy combined with immunotherapy and targeted drugs, along with concurrent or sequential radiotherapy, for the treatment of locally advanced unresectable esophageal cancer: A retrospective comparative study on safety and efficacy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132144

Registration Time: 2026/09/10

Type: Observational study

Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342351

Published by HT Digital Content Services with permission from Health Daily Digest....